VirtualScopics, Inc. (VSCP) Accepts Investment in New Business Venture from the Merck Global Health Innovation Fund
VirtualScopics, a leading provider of quantitative imaging, today announced they have finalized the initial closing in their sale of a new series of convertible preferred stock to the Merck Global Health Innovation Fund. The stock will be purchased for $3 million, with an additional $3 million investment contingent on the achievement of certain milestones. This sale is a portion of a larger investment to deliver funding for VirtualScopics’ efforts to grow its quantitative imaging technology into new markets, such as personalized medicine. VirtualScopics’ existing model employs its quantitative imaging technology for the characterization of structural and functional information, facilitating early…